Identification and validation of biomarkers in membranous nephropathy and pan-cancer analysis

被引:1
|
作者
Yang, Yue [1 ]
Zou, Gu-ming [1 ]
Wei, Xian-sen [1 ]
Zhang, Zheng [1 ]
Zhuo, Li [1 ]
Xu, Qian-qian [1 ]
Li, Wen-ge [1 ]
机构
[1] China Japan Friendship Hosp, Dept Nephrol, Beijing, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
membranous nephropathy; pan-cancer; differential expression gene; potential link; biomarkers; GLOMERULONEPHRITIS; ASSOCIATION; EXPRESSION; GENES;
D O I
10.3389/fimmu.2024.1302909
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Membranous nephropathy (MN) is an autoimmune disease and represents the most prevalent type of renal pathology in adult patients afflicted with nephrotic syndrome. Despite substantial evidence suggesting a possible link between MN and cancer, the precise underlying mechanisms remain elusive.Methods In this study, we acquired and integrated two MN datasets (comprising a single-cell dataset and a bulk RNA-seq dataset) from the Gene Expression Omnibus database for differential expression gene (DEG) analysis, hub genes were obtained by LASSO and random forest algorithms, the diagnostic ability of hub genes was assessed using ROC curves, and the degree of immune cell infiltration was evaluated using the ssGSEA function. Concurrently, we gathered pan-cancer-related genes from the TCGA and GTEx databases, to analyze the expression, mutation status, drug sensitivity and prognosis of hub genes in pan-cancer.Results We conducted intersections between the set of 318 senescence-related genes and the 366 DEGs, resulting in the identification of 13 senescence-related DEGs. Afterwards, we meticulously analyzed these genes using the LASSO and random forest algorithms, which ultimately led to the discovery of six hub genes through intersection (PIK3R1, CCND1, TERF2IP, SLC25A4, CAPN2, and TXN). ROC curves suggest that these hub genes have good recognition of MN. After performing correlation analysis, examining immune infiltration, and conducting a comprehensive pan-cancer investigation, we validated these six hub genes through immunohistochemical analysis using human renal biopsy tissues. The pan-cancer analysis notably accentuates the robust association between these hub genes and the prognoses of individuals afflicted by diverse cancer types, further underscoring the importance of mutations within these hub genes across various cancers.Conclusion This evidence indicates that these genes could potentially play a pivotal role as a critical link connecting MN and cancer. As a result, they may hold promise as valuable targets for intervention in cases of both MN and cancer.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers
    Wang, Yiyang
    Bi, Xiaojuan
    Luo, Zhiwen
    Wang, Haiyan
    Ismtula, Dilimulati
    Guo, Chenming
    FRONTIERS IN GENETICS, 2023, 14
  • [22] Pan-cancer analysis of KEAP1 mutations as biomarkers for immunotherapy outcomes
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Zhou, Caicun
    Jiang, Tao
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (04)
  • [23] Pan-Cancer Biomarkers Changing the Landscape of Molecular Testing
    Yao, Jinjuan
    Arcila, Maria E.
    Ladanyi, Marc
    Hechtman, Jaclyn F.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (06) : 692 - 698
  • [24] Identification and validation of SERPINE1 as a prognostic and immunological biomarker in pan-cancer and in ccRCC
    Li, Lingqin
    Li, Fan
    Xu, Zhehao
    Li, Liyang
    Hu, Haiyi
    Li, Yang
    Yu, Shicheng
    Wang, Mingchao
    Gao, Lei
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [25] Pan-cancer analysis of ARID1A Alterations as Biomarkers for Immunotherapy Outcomes
    Jiang, Tao
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Zhou, Caicun
    JOURNAL OF CANCER, 2020, 11 (04): : 776 - 780
  • [26] An integrative pan-cancer analysis of WWC family genes and functional validation in lung cancer
    Huang, Hongmei
    Gu, Jiaji
    Kuang, Xinjie
    Yu, Yonghui
    Rao, Boqi
    Fang, Shenying
    Lu, Jiachun
    Qiu, Fuman
    CELLULAR SIGNALLING, 2024, 115
  • [27] Pan-cancer bioinformatics analysis of hepatic leukemia factor and further validation in colorectal cancer
    Lin, Yirong
    Xiong, Zuming
    Yang, Yongjun
    Li, Wenxin
    Huang, Wei
    Lin, Minglin
    Zhang, Sen
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (07) : 3299 - 3317
  • [28] Identification of RNMT as an immunotherapeutic and prognostic biomarker: From pan-cancer analysis to lung squamous cell carcinoma validation
    Huang, Shuqiang
    Tan, Cuiyu
    Zheng, Jinzhen
    Huang, Zhugu
    Li, Zhihong
    Lv, Ziyin
    Chen, Wanru
    Chen, Miaoqi
    Yuan, Xiaojun
    Chen, Cairong
    Yan, Qiuxia
    IMMUNOBIOLOGY, 2024, 229 (05)
  • [29] The prognostic and immunological role of MYB: from bladder cancer validation to pan-cancer analysis
    Cui, Xiaobo
    Zhang, Chao
    Zhang, Liqi
    Yan, Huaqing
    BIOSCIENCE REPORTS, 2023, 43 (04)
  • [30] Novel Biomarkers in Membranous Nephropathy
    Liu, Qiuying
    Liu, Jianhua
    Lin, Baoxu
    Zhang, Yue
    Ma, Meichen
    Yang, Mei
    Qin, Xiaosong
    FRONTIERS IN IMMUNOLOGY, 2022, 13